Adoption of the income statements and the balance sheets

The annual general meeting adopted the presented income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet for 2025.

Disposition of the company’s results

The annual general meeting approved, in accordance with the board’s proposal, that no dividend shall be paid for the financial year 2025.

Discharge from liability

The annual general meeting resolved to discharge those who held the positions of board members and CEO from liability for the past year.

Board and auditors

The annual general meeting resolved, in accordance with the nomination committee’s proposal, that the board shall be composed of five members elected by the meeting, with no alternates, and that the number of auditors shall be one without an alternate.

The annual general meeting resolved, in accordance with the nomination committee’s proposal, to re-elect Jón Sigurdsson, Yonna Olsson, Victor Steien, Jens Viebke and Per Carlsson as board members for the time until the next annual general meeting. The annual general meeting also resolved, in accordance with the nomination committee’s proposal, to re-elect Jón Sigurdsson as chair of the board. In addition, the annual general meeting also resolved, in accordance with the nomination committee’s proposal, to elect the registered accounting firm KPMG AB as the company’s auditor, with the authorized auditor Jimmy Almqvist as auditor in charge.

The annual general meeting resolved, in accordance with the nomination committee’s proposal, that the fees to the board shall be SEK 800,000 to the chair of the board and SEK 175,000 to each of the other board members elected by the meeting. The annual general meeting also resolved, in accordance with the nomination committee’s proposal, that fees will be paid to the auditor in accordance with approved invoices.

Issue authorization

The annual general meeting resolved, in accordance with the board’s proposal, to authorize the board to, on one or several occasions before the next annual general meeting, issue new shares. Such share issues may deviate from the shareholders' preferential rights to subscribe for new shares. The issue of new shares may only increase the total number of shares by 900,000 shares, corresponding to approximately 10 percent of the total number of shares in the company as of the date of the notice.

Principles for the establishment of the nomination committee

The annual general meeting resolved, in accordance with the nomination committee's proposal, to adopt principles for the establishment of the nomination committee.

Contact Details

Ulrik Berthelsen

CEO & President

+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se

About Us

Stille AB (publ) is a well-established pioneer in the development, manufacturing and distribution of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high-precision procedures. Stille was founded in 1841 and is listed on Nasdaq First North Growth Market under the ticker “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, +46 8 684 211 10, adviser@eminova.se. More information is available at www.stille.se.